Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tailoring arthritis therapy in the wake of the NSAID crisis.

× No keyword cloud information.

7 in total

1. Private-sector research ethics: marketing or good conflicts management? The 2005 John J. Conley Lecture on Medical Ethics.

Authors: Rebecca Dresser
Journal: Theor Med Bioeth Date: 2006

Review 2. The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks.

Authors: J A Cairns
Journal: Can J Cardiol Date: 2007-02 Impact factor: 5.223

3. Therapy: Cardiovascular safety of celecoxib, naproxen and ibuprofen.

Authors: Michael T Nurmohamed
Journal: Nat Rev Rheumatol Date: 2017-01-27 Impact factor: 20.543

4. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4.

Authors: Robert B Zurier; Yee-Ping Sun; Kerri L George; Judith A Stebulis; Ronald G Rossetti; Ann Skulas; Erica Judge; Charles N Serhan
Journal: FASEB J Date: 2009-01-05 Impact factor: 5.191

Review 5. Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials.

Authors: P A Scott; G H Kingsley; C M Smith; E H Choy; D L Scott
Journal: Ann Rheum Dis Date: 2007-03-07 Impact factor: 19.103

6. Treatment of rheumatoid arthritis with marine and botanical oils: influence on serum lipids.

Authors: Barbara C Olendzki; Katherine Leung; Susan Van Buskirk; George Reed; Robert B Zurier
Journal: Evid Based Complement Alternat Med Date: 2011-10-09 Impact factor: 2.629

7. Treatment of rheumatoid arthritis with marine and botanical oils: an 18-month, randomized, and double-blind trial.

Authors: George W Reed; Katherine Leung; Ronald G Rossetti; Susan Vanbuskirk; John T Sharp; Robert B Zurier
Journal: Evid Based Complement Alternat Med Date: 2014-03-19 Impact factor: 2.629

7 in total